+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Viral load of human papillomavirus and risk of CIN3 or cervical cancer

Viral load of human papillomavirus and risk of CIN3 or cervical cancer

Lancet 360(9328): 228-229

Carcinogenic human papillomaviruses (HPV) are thought to be necessary for development of cervical cancer. We assessed whether higher viral loads of such viruses predicted future risk of CIN3 or cancer (CIN3+) in a cohort of 20810 women followed up for 10 years with cytological screening. We measured the viral load for 13 types of carcinogenic HPV (relative light units normalised to 1 pg/mL HPV 16 positive controls [RLU/PC]) using Hybrid Capture 2 testing of cervicovaginal lavages obtained at enrolment. Results were stratified into four groups (RLU/PC 1 to <10, 10 to <100, 100 to <1000, > or = 1000). Although presence of HPV strongly increased risk of CIN3+, high viral load did not further predict risk of CIN3+.

(PDF emailed within 0-6 h: $19.90)

Accession: 011641635

Download citation: RISBibTeXText

PMID: 12133661

DOI: 10.1016/s0140-6736(02)09463-1

Related references

Semiquantitative human papillomavirus type 16 viral load and the prospective risk of cervical precancer and cancer. Cancer Epidemiology, Biomarkers & Prevention 14(5): 1311-1314, 2005

Evaluation of Viral Load as a Triage Strategy With Primary High-Risk Human Papillomavirus Cervical Cancer Screening. Journal of Lower Genital Tract Disease 21(1): 12-16, 2016

Human papillomavirus genotype distribution and socio-behavioural characteristics in women with cervical pre-cancer and cancer at the start of a human papillomavirus vaccination programme: the CIN3+ plus study. Bmc Cancer 19(1): 111-111, 2019

Long-term risk of cervical intraepithelial neoplasia grade 3 or worse according to high-risk human papillomavirus genotype and semi-quantitative viral load among 33,288 women with normal cervical cytology. International Journal of Cancer 137(1): 193-203, 2015

High viral load, persistent human papillomavirus infection and risk of cervical dysplasia. Proceedings of the American Association for Cancer Research Annual Meeting 40: 570, 1999

Viral load of high-risk human papillomavirus in cervical squamous intraepithelial lesions. International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics 76(1): 41-47, 2002

Analysis of the dose-response relationship between high-risk human papillomavirus viral load and cervical lesions. Transactions of the Royal Society of Tropical Medicine and Hygiene 103(8): 779-784, 2010

Human papillomavirus type 16 viral load in relation to HIV infection, cervical neoplasia and cancer in Senegal. Cancer Epidemiology 38(4): 369-375, 2015

Viral load, genomic integration frequency of human papillomavirus 16 in cervical cancer and precancerous lesions. Zhonghua Yi Xue Za Zhi 91(13): 906-910, 2011

Association of human papillomavirus viral load and risk of cervical squamous intraepithelial lesions among multiethnic women in Hawaii. Proceedings of the American Association for Cancer Research Annual Meeting 40: 444, 1999

Integrated human papillomavirus types 52 and 58 are infrequently found in cervical cancer, and high viral loads predict risk of cervical cancer. Gynecologic Oncology 102(1): 54-60, 2006

Consistent high viral load of human papillomavirus 16 and risk of cervical carcinoma in situ: a nested case-control study. Lancet 355(9222): 2194-2198, 2000

Prognostic significance of human papillomavirus viral load in correlation with different therapeutic modalities in cervical cancer patients. Pathology, Research and Practice 212(9): 804-810, 2017

Value of high risk human papillomavirus viral load in predicting cervical lesions and triaging for high risk (HR)-HPV-positive women. Zhonghua Zhong Liu Za Zhi 36(4): 316-320, 2014

The majority of metachronous CIN1 and CIN3 lesions are caused by different human papillomavirus genotypes, indicating that the presence of CIN1 seems not to determine the risk for subsequent detection of CIN3. Human Pathology 45(2): 221-226, 2014